Shiina Shunsuke, Kanemura Ayaka, Suzuki Chihiro, Yamaki Fumiko, Obara Keisuke, Chino Daisuke, Tanaka Yoshio
Department of Chemical Pharmacology, Faculty of Pharmaceutical Sciences, Toho University, 2-2-1 Miyama, Funabashi-City, Chiba 274-8510, Japan.
Department of Pharmacotherapy, Faculty of Pharmaceutical Sciences, Nihon Pharmaceutical University, 10281 Komuro, Ina-machi, Kita-Adachi-gun, Saitama 362-0806, Japan.
J Smooth Muscle Res. 2018;54(0):1-12. doi: 10.1540/jsmr.54.1.
Object We identified the β-adrenoceptor (β-AR) subtypes responsible for the relaxant responses to adrenaline (AD) and noradrenaline (NA) in the rat thoracic aorta and examined the role of cAMP which is involved in these relaxant responses. Methods The effects of β-AR antagonists or the adenylyl cyclase inhibitor SQ 22,536 on AD- and NA-induced relaxant responses in phenylephrine-induced contraction and increases in cAMP levels were examined in isolated, endothelium-denuded rat thoracic aorta segments. Results AD-induced relaxation was completely suppressed by propranolol (10 M) or by ICI-118,551 (10 M) plus atenolol (10 M), and was also very strongly inhibited by ICI-118,551 (10 M) alone. AD (10 M) increased tissue cAMP levels by approximately 1.9-fold compared with that in non-stimulated aortic tissue, but did not significantly increase cAMP levels in the presence of ICI-118,551 (10 M) or SQ 22,536 (10 M). AD-induced relaxation was strongly suppressed by SQ 22,536 (10 M). NA-induced relaxation was almost completely suppressed by atenolol (10 M) plus ICI-118,551 (10 M) although it was hardly affected by ICI-118,551 (10 M) alone. NA (10 M) increased tissue cAMP levels by approximately 2.2-fold compared with that in non-stimulated aortic tissue, but did not significantly increase cAMP levels in the presence of atenolol (10 M) or SQ 22,536 (10 M). NA-induced relaxation was strongly suppressed by SQ 22,536 (10 M). Conclusion In rat thoracic aorta, AD- and NA-induced relaxations, which are both strongly dependent on increased tissue cAMP levels, are mainly mediated through β- and β-adrenoceptors respectively.
我们确定了负责大鼠胸主动脉对肾上腺素(AD)和去甲肾上腺素(NA)舒张反应的β-肾上腺素能受体(β-AR)亚型,并研究了参与这些舒张反应的环磷酸腺苷(cAMP)的作用。方法:在离体、去内皮的大鼠胸主动脉段中,检测β-AR拮抗剂或腺苷酸环化酶抑制剂SQ 22,536对苯肾上腺素诱导的收缩中AD和NA诱导的舒张反应以及cAMP水平升高的影响。结果:普萘洛尔(10 μM)或ICI-118,551(10 μM)加阿替洛尔(10 μM)可完全抑制AD诱导的舒张,单独使用ICI-118,551(10 μM)也能非常强烈地抑制该反应。与未刺激的主动脉组织相比,AD(10 μM)可使组织cAMP水平升高约1.9倍,但在存在ICI-118,551(10 μM)或SQ 22,536(10 μM)时,cAMP水平未显著升高。SQ 22,536(10 μM)可强烈抑制AD诱导的舒张。阿替洛尔(10 μM)加ICI-118,551(10 μM)几乎可完全抑制NA诱导的舒张,尽管单独使用ICI-118,551(10 μM)对其影响不大。与未刺激的主动脉组织相比,NA(10 μM)可使组织cAMP水平升高约2.2倍,但在存在阿替洛尔(10 μM)或SQ 22,536(10 μM)时,cAMP水平未显著升高。SQ 22,536(10 μM)可强烈抑制NA诱导的舒张。结论:在大鼠胸主动脉中,AD和NA诱导的舒张均强烈依赖于组织cAMP水平的升高,分别主要通过β₂和β₁ - 肾上腺素能受体介导。